Use of 2-amino-2h-quinazoline derivatives for producing therapeutic agents
OwnerRolf Sachseinventor
Life of this patent
Estimating the term…
Abstract
The invention concerns the use of 2-amino-2H-quinazoline derivatives of general chemical formula (I), wherein R1 indicates an alkyl group with 1-5 carbon atoms and R2, R3, R4 and R5, independently of one another, each indicate a chlorine or hydrogen atom, as well as their pharmaceutically compatible salts, for producing therapeutic agents for the treatment of myeloproliferative diseases, high blood pressure and for bronchodilation.
Claims8
Use of 2-amino-2H-quinazoline derivatives of the general chemical formula I
- wherein R1 is an alkyl group with 1-5 carbon atoms and R2, R3, R4 and R5, independently of one another, each indicate a chlorine or hydrogen atom, as well as their pharmaceutically compatible salts, for producing therapeutic agents for the treatment of myeloproliferative diseases and for bronchodilation in mammals.
Use of 2-amino-2H-quinazoline derivatives of the general chemical formula I
- wherein R1 indicates an alkyl group with 1-5 carbon atoms and R2, R3, R4 and R5, independently of one another, each indicate a chlorine or hydrogen atom, and their pharmaceutically compatible salts, for the treatment of myeloproliferative diseases and for bronchodilation in mammals.
Use of a pharmaceutical preparation containing at least one agent, selected from the group comprising 2-amino-2H-quinazoline derivatives of the general chemical formula I
- wherein R1 is an alkyl group with 1-5 carbon atoms and R2, R3, R4 and R5, independently of one another, each indicate a chlorine or hydrogen atom, and their pharmaceutically compatible salts, and at least one pharmaceutically compatible adjuvant, for the treatment of myeloproliferative diseases and for bronchodilation in mammals.
Dependencies are inferred from the claim text.